Drug Price Trends for FT CHILD IBUPROFEN

Average Pharmacy Cost for FT CHILD IBUPROFEN

These are average pharmacy acquisition costs (net of discounts) from a US national survey

Drug Name	NDC	Price/Unit ($)	Unit	Date
FT CHILD IBUPROFEN 100 MG/5 ML	70677-1116-01	0.03474	ML	2024-12-18
FT CHILD IBUPROFEN 100 MG/5 ML	70677-1115-02	0.03016	ML	2024-12-18
FT CHILD IBUPROFEN 100 MG/5 ML	70677-1118-01	0.03474	ML	2024-12-18

FT CHILD IBUPROFEN Market Analysis and Financial Projection

Market Analysis and Price Projections for FT Children's Ibuprofen

Market Overview

The market for antipyretic drugs, including ibuprofen, has been experiencing significant growth driven by several key factors. Here are some critical points to consider when analyzing the market for FT Children's Ibuprofen.

Global Antipyretic Drugs Market

The global antipyretic drugs market for children is projected to grow from $3.02 billion in 2023 to $3.21 billion in 2024, with a compound annual growth rate (CAGR) of 6.4%. This growth is attributed to increasing awareness of pediatric health, rising healthcare expenditures, and growing access to over-the-counter antipyretic drugs in emerging markets[1].

Ibuprofen Market Specifics

The global ibuprofen market, which includes FT Children's Ibuprofen, was valued at USD 1.43 billion in 2023 and is expected to reach USD 1.76 billion by 2032, growing at a CAGR of 2.44% during the forecast period. This growth is driven by factors such as rising urbanization, increasing public awareness of chronic diseases, and growing healthcare spending[3].

Market Segmentation

By Drug Class

The antipyretic drugs market is segmented by drug class, with ibuprofen being a significant segment. Ibuprofen is widely used for its efficacy in reducing fever and relieving pain in children[1].

By Dosage Form

FT Children's Ibuprofen is available in various dosage forms, including chewable tablets and syrups. These forms are popular due to their ease of administration and palatability for children[1].

By Age Group

The market is also segmented by age group, including newborns, infants, toddlers, and children. FT Children's Ibuprofen is specifically formulated for these age groups, making it a crucial product in this segment[1].

Regional Analysis

Asia-Pacific

The Asia-Pacific region is a significant market for ibuprofen, driven by low manufacturing costs in countries like China and India. This region is expected to expand substantially during the forecast period due to rising healthcare expenditures and a growing aging population[3][4].

North America

North America is also a key market, with a growing demand for ibuprofen driven by increasing consumer awareness of over-the-counter medications and the trend towards self-medication for minor ailments[3].

Price Projections and Market Dynamics

Current Pricing

The current counter price for FT Ibuprofen IB Children's can range from $18.39 for a 3-bottle pack of 24 tablets, though discounts and coupons can reduce the cost significantly[5].

Price Gouging Concerns

There have been concerns about price gouging, particularly during times of high demand such as the "tripledemic" of COVID-19, RSV, and the flu. Regulatory bodies have cautioned against excessive price increases, urging consumers to report any dramatic price hikes[2].

Forecasted Prices

Given the projected growth in the ibuprofen market, prices are likely to remain competitive. However, any significant increase in raw material costs, manufacturing expenses, or regulatory changes could impact pricing. The overall trend suggests stable to slightly increasing prices due to growing demand and healthcare expenditures[3][4].

Technological Innovations and Trends

Technological Innovations

Technological innovations in pediatric drug formulations are expected to enhance the efficacy and safety of antipyretic drugs like ibuprofen. Faster and safer fever relief formulations are being developed, which could influence pricing and market share[1].

Natural and Herbal-Based Antipyretics

There is a growing trend towards natural and herbal-based antipyretic drugs for children. While this trend may not directly impact FT Children's Ibuprofen, it could influence consumer preferences and market dynamics[1].

Personalized Pediatric Treatments

The increasing focus on personalized pediatric treatments could lead to more tailored and effective antipyretic medications. This might result in premium pricing for such specialized products[1].

Key Takeaways

• The global antipyretic drugs market for children, including ibuprofen, is growing steadily due to increasing awareness of pediatric health and rising healthcare expenditures.
• The ibuprofen market is expected to grow at a CAGR of 2.44% from 2023 to 2032.
• FT Children's Ibuprofen is available in various dosage forms and is segmented by age group, catering to different pediatric needs.
• Regional markets, especially Asia-Pacific, are significant due to low manufacturing costs and rising healthcare expenditures.
• Price gouging is a concern during high-demand periods, and regulatory bodies are vigilant about excessive price increases.
• Technological innovations and trends towards natural and personalized treatments are shaping the market.

FAQs

What is the current market size of the global antipyretic drugs market for children?

The global antipyretic drugs market for children was valued at $3.02 billion in 2023 and is expected to grow to $3.21 billion in 2024[1].

How is the ibuprofen market expected to grow in the coming years?

The global ibuprofen market is expected to grow from USD 1.43 billion in 2023 to USD 1.76 billion by 2032, at a CAGR of 2.44%[3].

What are the key drivers of the ibuprofen market?

Key drivers include rising urbanization, increasing public awareness of chronic diseases, and growing healthcare spending[3].

Which region is expected to dominate the ibuprofen market?

The Asia-Pacific region is expected to be the largest market shareholder due to low manufacturing costs and rising healthcare expenditures[3][4].

Are there any concerns about price gouging in the antipyretic drugs market?

Yes, there have been concerns about price gouging, especially during times of high demand such as the "tripledemic" of COVID-19, RSV, and the flu[2].

What technological innovations are expected in the antipyretic drugs market?

Technological innovations include faster and safer fever relief formulations, natural and herbal-based antipyretic drugs, and personalized pediatric treatments[1].

How does the trend towards natural and herbal-based antipyretics impact the market?

The trend towards natural and herbal-based antipyretics could influence consumer preferences and market dynamics, potentially leading to a shift in demand[1].

Sources

1. The Business Research Company, "Antipyretic Drugs For Children Global Market Report 2024"
2. New York State Office of the Attorney General, "CONSUMER ALERT: Attorney General James Cautions Against Price Gouging of Children’s Medication"
3. Straits Research, "Global Ibuprofen Market Size, Top Share, CAGR of 2.44%, Report 2024"
4. Research Nester, "Ibuprofen API Market Size & Share, Growth Trends 2037"
5. SingleCare, "FT Ibuprofen IB Childrens Coupons & Prices"